Furthermore, our study identified hsa-miR-217, hsa-miR-203a-3p.2, and hsa-miR-6766-3p as potential regulators of CDH1, CDH2, and CDH3 in NSCLC. This evidence concerns the gene CDH2 and non-small cell lung carcinoma.